Aragen Life Sciences Limited

Aragen Life Sciences Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials and compliance.
CIN U74999TG2000PLC035826 Incorporated 07 December 2000 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹1,870.29 Cr
▲ 12.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹250 Cr
Registered with MCA
Paid-up capital
₹216.99 Cr
Issued & subscribed
Open charges
₹583.8 Cr
Satisfied ₹768.38 Cr
Company age
26 yrs
Est. 2000
Employees · EPFO
3,859
Latest available

About Aragen Life Sciences Limited

Data last updated: 17 December 2025

Aragen Life Sciences Limited is a public limited company based in Hyderabad, Telangana, India. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 07 December 2000, the company has been in operation for over 26 years.

Registered with ROC Hyderabad under CIN U74999TG2000PLC035826.

Capital: an authorised share capital of ₹250 Cr and a paid-up capital of ₹216.99 Cr. Formerly known as Gvk Biosciences Private Limited. It is led by directors including Davinder Singh Brar and Amit Varma.

Last AGM: 27 June 2025. Financial statements filed for year ended 31 March 2024. Office: Plot 28A Ida Nacharam, Hyderabad, Telangana, India – 500076.

As per the financials filed for FY 2025, the company reported a revenue of ₹1,870.29 Cr, a growth of 12% compared to the previous year.

The company has a workforce of approximately 3,859 employees as per the latest available data. Its group structure includes 2 subsidiaries.

The company is associated with 2 brands - Gvk Davix Technologies, Aragen Life Sciences. As per MCA filings, the company has open charges of ₹583.8 Cr and satisfied charges of ₹768.38 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website gvkbio.com.

Company Details of Aragen Life Sciences Limited
CIN U74999TG2000PLC035826
Registration Number 035826
Incorporation Date 07 December 2000
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 June 2025
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    Plot 28A Ida Nacharam, Hyderabad, Telangana, India – 500076
  • Industry
    Pharma, Pharma Contract R&D
Company report
Aragen Life Sciences Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Aragen Life Sciences Limited report

Financials, compliance, directors, charges, ownership and filings for Aragen Life Sciences Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Aragen Life Sciences Limited

Aragen Life Sciences Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U74999TG2000PLC035826, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U74999TG2000PLC035826 Current
U74999AP2000PTC035826 Previous
U74999TG2000PTC035826 Previous

Associated Brands with Aragen Life Sciences Limited

Aragen Life Sciences Limited operates two associated brands: GVK Davix Technologies and Aragen Life Sciences. These brands represent Aragen Life Sciences Limited's diversified market presence and brand portfolio.

Brand Description Website
Provider of drug preclinical and formulation development services gvkbio.com
Aragen Life Sciences is engaged in contract research and manufacturing for pharmaceuticals. aragen.com

Competitors & Alternatives of Aragen Life Sciences Limited

Brands and companies operating in the same space as Aragen Life Sciences Limited include Nephron Pharmaceuticals, Suanfarma, Hybio Pharmaceutical and 5 more.

Competitor Description Location Founded
Nephron Pharmaceuticals Nephron Pharmaceuticals Sterile pharmaceutical products are manufactured and contract services are provided. Florida, Puerto Rico, United States 1937
Suanfarma Suanfarma Generics, nutraceuticals, and APIs are developed by Suanfarma. Madrid, Spain, Spain 1993
Hybio Pharmaceutical Hybio Pharmaceutical Polypeptide drugs and APIs are developed and manufactured. Shenzhen, China, China 1998
OneSource OneSource Pharmaceutical contract development and manufacturing services are offered by OneSource. Bengaluru, India, India 2023
Wheeler Bio Wheeler Bio Provider of drug research and analytical development services for multiple therapeutic areas Oklahoma City, United States, United States 2020
Aiolos Bio Aiolos Bio Biotech company focused on developing innovative therapies for respiratory diseases and immune conditions Boston, United States, United States 2023
Kardigan Kardigan Biotech company developing personalized medicines for cardiovascular diseases San Francisco, United States, United States 2023
AmbioPharm AmbioPharm CDMO and analytical services for peptide development are provided. North Augusta, United States, United States 2006

Business Activity of Aragen Life Sciences Limited

Aragen Life Sciences Limited is engaged in principal business activities including professional, scientific and technical and manufacturing, with detailed activities including scientific research and development, chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
M Professional, Scientific and Technical M5 Scientific research and development Locked
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Aragen Life Sciences Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Aragen Life Sciences Limited

Aragen Life Sciences Limited is audited by BSR & Co for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
BSR & Co Locked Locked Locked
Premium access

Complete auditor history for Aragen Life Sciences Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors and KMP of Aragen Life Sciences Limited

Aragen Life Sciences Limited currently reports 8 directors and 1 key managerial person. 19 former directors have served the organization.

Current Directors and KMP
Name Designation Appointment Date Tenure Status
Davinder Singh Brar Director 26 Jul 2004 22 Years 0 Months Current
Amit Varma Director 09 Jan 2025 1 Years 7 Months Current
Ajay Srivastava Director 20 May 2021 5 Years 2 Months Current
Anita Ramachandran Director 07 Nov 2022 3 Years 9 Months Current
Rajat Sood Director 19 May 2021 5 Years 2 Months Current
Manmahesh Kantipudi Managing Director 29 May 2018 8 Years 2 Months Current
Showing 6 of 9 current directors and KMP. View all directors and KMP

Financials of Aragen Life Sciences Limited FY 2024 filings available

Aragen Life Sciences Limited reported revenue of ₹1,870.29 Cr (up 12.00% YoY) for FY 2025.

Revenue · FY 2025
₹1,870.29 Cr ▲ 12.00%
Premium access

Ten-year financial statements for Aragen Life Sciences Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Aragen Life Sciences Limited

Premium access

Shareholding and ownership data for Aragen Life Sciences Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Group Structure of Aragen Life Sciences Limited

Aragen Life Sciences Limited has 2 subsidiary companies. This group structure data is as of FY 2023. The corporate group structure reflects Aragen Life Sciences Limited's business expansion strategy and organizational complexity.

2
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Intox Private Limited U74999PN2000PTC015116 Locked
Aragen Foundation U85300DL2021NPL391515 Locked

Showing major subsidiaries. Total: 2.

Charges & Borrowings of Aragen Life Sciences Limited

Open charges
₹583.8 Cr
Satisfied charges
₹768.38 Cr
Breakdown by lending institutions
Others₹325.00 Cr
Citi Bank N.A.₹201.80 Cr
Yes Bank Limited₹57.00 Cr
Latest charge details
DateLenderAmountStatus
15 Apr 2025 Citi Bank N.A. ₹100 Cr Open
28 Mar 2024 Others ₹50 Cr Open
07 Dec 2021 Citi Bank N.A. ₹50 Cr Open
08 Nov 2021 Others ₹100 Cr Open
31 Mar 2020 Others ₹75 Cr Open

Total charge records: 27 View all charges

Employees and EPFO Compliance at Aragen Life Sciences Limited

Aragen Life Sciences Limited has a workforce of 3,859 employees as of Apr 08, 2024.

Employee count
3,859
Active EPFO establishments
1
Employee growth
-1.71%
Premium access

Employee and EPFO history for Aragen Life Sciences Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Aragen Life Sciences Limited

Premium access

GST registrations and filing compliance for Aragen Life Sciences Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Aragen Life Sciences Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Aragen Life Sciences Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Aragen Life Sciences Limited

Premium access

MSME payment history for Aragen Life Sciences Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Aragen Life Sciences Limited

Premium access

Corporate group structure for Aragen Life Sciences Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Aragen Life Sciences Limited

Premium access

MCA filings and documents for Aragen Life Sciences Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Aragen Life Sciences Limited

Charges
20 Sep 2025
A charge registered on 17 Aug 2023 via Charge ID 100774202 with Citi Bank N.A. was fully satisfied on 20 Sep 2025.
Activity
27 Jun 2025
Aragen Life Sciences Limited last Annual general meeting of members was held on 27 Jun 2025 as per latest MCA records.
Charges
15 Apr 2025
A charge with Citi Bank N.A. amounted to Rs. 100.00 Cr with Charge ID 101090128 was registered on 15 Apr 2025.
Charges
26 Mar 2025
A charge with Others of Rs. 100.00 Cr registered on 08 Nov 2021 with Charge ID 100505209 was modified on 26 Mar 2025.
Charges
20 Mar 2025
A charge registered on 10 Feb 2022 via Charge ID 100558920 with Idbi Trusteeship Services Limited was fully satisfied on 20 Mar 2025.
Directors
09 Jan 2025
Amit Varma was appointed as a Director on 09 Jan 2025 & has been associated with this company since 1 year 7 months.

Frequently Asked Questions about Aragen Life Sciences Limited

Aragen Life Sciences Limited is an active public limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 07 December 2000 (26+ years old) and is registered under CIN U74999TG2000PLC035826. The company has 3,859 employees.

Aragen Life Sciences Limited reported revenue of ₹1,870.29 Cr for FY 2025 (up 12.00% YoY).

The current directors and KMP of Aragen Life Sciences Limited are:

The primary industry of Aragen Life Sciences Limited is pharma. The company specifically operates in pharma contract r and d. The company is currently active in this sector.

Aragen Life Sciences Limited can be reached at the registered office: Plot 28A Ida Nacharam, Hyderabad, Telangana, India – 500076, or through the website gvkbio.com.

The authorised capital is ₹250 Cr, and the paid-up capital is ₹216.99 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available